ʻO Henry Ji
Lunahoomalu, Pelekikena a me CEO
- ʻO 25+ mau makahiki o ka ʻike ma ka ʻoihana biotechnology a me ka ʻepekema ola
- Ua hoʻokumu pū ʻo Dr. Ji iā Sorrento a ua lawelawe ʻo ia ma ke ʻano he alakaʻi mai ka makahiki 2006, Luna Nui a me Pelekikena mai 2012, a ʻo Pelekikena mai 2017.
- I kona noho ʻana ma Sorrento, ua hana ʻo ia a alakaʻi i kahi ulu kupaianaha o Sorrento ma o ka loaʻa ʻana a me ka hui pū ʻana me Bioserv, Scilex Pharmaceuticals, Concortis Biotherapeutics, Levena Biopharma, LACEL, TNK Therapeutics, Virttu Biologics, Ark Animal Health, a me Sofusa Lymphatic Delivery.
- Ua lawelawe ʻo ia ma ke ʻano he Luna Nui ʻepekema ʻo Sorrento mai 2008 a i 2012 a ʻo kāna Luna Nui Interim mai 2011 a 2012.
- Ma mua o Sorrento, ua paʻa ʻo ia i nā kūlana hoʻokō kiʻekiʻe ma CombiMatrix, Stratagene a ua hoʻokumu pū ʻia ʻo Stratagene Genomics, kahi lālā o Stratagene, a ua lawelawe ʻo ia ma kāna Pelekikena & Luna Nui a me Luna Hoʻokele o ka Papa
- BS a me Ph.D.
Pani >
Mike Royal
Kauka Lapaʻau
- He luna lapaʻau ʻo Dr. Royal me 20 mau makahiki o ka hoʻomohala ʻana i nā lāʻau lapaʻau a me nā hana lapaʻau. ʻO ka mea i hala koke aku nei, ʻo ia ka Luna Lapaʻau Nui o Suzhou Connect Biopharmaceuticals a, ma mua o kēlā, Concentric Analgesics. Ua hui hou ʻo ia iā Sorrento kahi i lilo ai ʻo ia i EVP, Clinical Development and Regulatory Affairs ma 2016.
- Ua kuleana ʻo ia no nā NDA kūleʻa, me nā NCE, 505(b)(2)s a me nā ANDA.
- Ua hoʻopaʻa ʻia ʻo Dr. Royal i ka lāʻau lapaʻau kūloko, lāʻau ʻeha, anesthesiology me nā hōʻailona ʻē aʻe i ka mālama ʻana i ka ʻeha, ka lāʻau addiction a me ka lāʻau lapaʻau.
- He Kauka Kokua ʻo ia i ka lāʻau lapaʻau ma ka Uniformed Services University of Health Science, Assistant Professor of Anesthesiology/Critical Care Medicine ma ke Kulanui o Pittsburgh Medical Center, a he Kumu Adjunct ma ke Kulanui o Oklahoma a me ke Kulanui o Kaleponi San Diego.
- Ua paʻi nui ʻo ia me nā mokuna puke he 190, nā ʻatikala i loiloi ʻia e nā hoa a me nā abstracts/posters; a ua kono ʻia ʻo ia i ka haʻiʻōlelo ma nā hālāwai aupuni a me ka honua
- BS, MD, JD, MBA
Pani >
Elizabeth Czerepak
Hope Pelekikena Hoʻokō, Luna Nui Waiwai, Luna Nui ʻOihana
- ʻO 35+ mau makahiki o ka ʻike kālā a me ka hana i ka biotech a me nā lāʻau lapaʻau
- Ua hoʻohana ʻo Ms. Czerepak i 18 mau makahiki ma Pharma nui a he 11 mau makahiki ma ke ʻano he CFO o nā biotechs like ʻole, kahi āna i alakaʻi ai i ke kālā, ka hui ʻana a me nā hana M&A. Hoʻomaka ʻo ia i kāna ʻoihana ma Merck & Co., he kuleana koʻikoʻi i ka loaʻa ʻana o Syntex iā Roche i $5.4B, a alakaʻi i nā hana hoʻoikaika ʻana no Humira® i hoʻopau i ke kūʻai aku ʻo BASF Pharma i $6.8B iā Abbott.
- No ʻeiwa mau makahiki ma ke ʻano he Luna Hoʻokele ma JP Morgan lāua ʻo Bear Stearns, ua hoʻokumu ʻo ia i hoa hui nui o kahi waihona kālā $212M, kahi i alakaʻi ai i nā hoʻopukapuka ma 13 biotechs, lawelawe ma nā papa a hoʻomaʻamaʻa i nā puka ma o IPO a me ka loaʻa. Māhele 7 a me Series 63 FINRA (NASD) Lunamakaʻāinana i kākau inoa ʻia mai 2001 a 2008.
- ʻO ka lālā o ka papa ʻike (me Sorrento a me Scilex) a me ka luna hoʻokele loiloi, loaʻa iā ia kahi Palapala Luna Hoʻokele ʻoihana mai Harvard Business School ma 2020.
- BA a me MBA
Pani >
Mark R. Brunswick
Hope Peresidena kiʻekiʻe ʻOihana Hoʻoponopono
- Ua ʻoi aku ʻo Dr. Brunswick ma mua o 35 mau makahiki o nā kūlana kiʻekiʻe ma Regulated Industry me nā makahiki he 9 i ka US FDA, Center for Biologics, Division of Monoclonal Antibodies.
- Ma mua o kona komo ʻana i Sorrento, ʻo Kauka Brunswick ke poʻo o ka Regulatory Affairs and Quality ma Sophiris Bio, kahi hui e hoʻomohala nei i kahi lāʻau lapaʻau no ka maʻi maʻi prostate a me ka maʻi prostate. Ma mua o kēlā, ʻo ia ke poʻo o ka Regulatory Affairs ma Arena Pharmaceuticals i ʻike i nā lāʻau lapaʻau i kuhikuhi ʻia i nā mea hoʻokipa G Protein.
- Ua alakaʻi ʻo Dr. Brunswick i ka hui hoʻoponopono ma Elan Pharmaceuticals e noʻonoʻo ana i ka maʻi Alzheimer a me ka hui ʻeha, ziconotide
- BS a me Ph.D.
Pani >
Robert D. Allen
Hope Pelekikena Nui R&D
- Ua hala ʻo Kauka Allen ma mua o 15 mau makahiki i ka ʻoihana biotechnology e alakaʻi ana i ka noiʻi, hoʻomohala preclinical, a me ka hana mua ʻana o nā lāʻau antiviral a me ka maʻi kanesa.
- Ma mua o kona komo ʻana i Sorrento, ua lawelawe ʻo Dr. Allen ma ke ʻano he Luna Hoʻonaʻauao ʻepekema o ka Oregon Translational Research and Development Institute (OTRADI), e hui pū ana me nā ʻoihana a me nā hoa hoʻonaʻauao ma ka ʻike ʻana i ka lāʻau lapaʻau a me nā hoʻolaha hoʻolaha moho e kuhikuhi ana i nā maʻi maʻi hematologic, nā ʻōpū paʻa, a me nā pathogens maʻi infectious.
- Ma mua o OTRADI, ua hoʻomohala ʻo Dr. Allen i nā papahana ʻike ma SIGA Technologies i ʻike i nā antiviral hana pololei e huli ana i nā maʻi i loko o ka bunyavirus a me nā ʻohana filovirus a me nā mea hoʻokipa i alakaʻi ʻia e kūʻē i kahi ākea ākea o nā maʻi maʻi kanaka a koi aku i nā bacteria intracellular.
- BS a me Ph.D.
Pani >
Xiao Xu
Peresidena ACEA
- Ua ʻoi aku ʻo Dr. Xu ma mua o 20 mau makahiki ma ke ʻano he luna hoʻokō i nā ʻoihana biotech. ʻO Kauka Xu he mea hoʻokumu, pelekikena a Luna Nui o ACEA Biosciences (loaʻa iā Agilent ma 2018) a me ACEA Therapeutics (loaʻa e Sorrento Therapeutics i ka makahiki 2021). Hoʻohui ʻo ia Sorrento Therapeutics ma hope o ka loaʻa ʻana, a ke hoʻomau nei i ka hana ma ke ʻano he Pelekikena o ACEA, he lālā o Sorrento Therapeutics.
- Ua hoʻokele a kuleana ʻo ia no ka hoʻomohala ʻana i ka pipeline lāʻau hou o ACEA, nā noiʻi lapaʻau, a me ka hale hana cGMP.
- ʻO ia ka mea nāna i hoʻokumu i ka ʻenehana hoʻonaʻauao manuahi manuahi manuahi a me ke kuleana no ka ʻenehana/hoʻomohala huahana a me ka hui ʻoihana me Roche Diagnosis, ka hoʻolaha ʻana o ka ʻenehana a me nā huahana waiwai o ACEA, a me $250 miliona Agilent loaʻa o ACEA Biosciences.
- He mea noiʻi limahana a he ʻepekema noiʻi ʻo ia ma Gladstone Institutes, The Scripps Research Institute a me US Centers for Disease Control and Prevention. Loaʻa iā ia ma luna o 50 mau palapala patent a me nā palapala patent a ua hoʻopuka ʻo ia ma luna o 60 mau ʻatikala noiʻi ma nā nūpepa honua, me ka Science, PNAS, Nature Biotechnology, a me Chemistry and Biology.
- BS, MS, a me MD
Pani >
Shawn Sahebi
Hope Peresidena Kiʻekiʻe ʻOihana Kalepa
- Ke alakaʻi nei ʻo Kauka Sahebi i nā hana ʻoihana kalepa a Sorrento
- Lawe mai ma mua o 30 mau makahiki o ka ʻike lāʻau lapaʻau me ka ʻepekema kūʻai aku a me ka hoʻolālā pāʻoihana i Sorrento
- Ma mua o kona komo ʻana i Sorrento, ua paʻa ʻo ia i nā kūlana hoʻokele kiʻekiʻe me Novartis, Pfizer, a me Lilly e hoʻomohala ana i ka ʻikepili kalepa a me nā hoʻolālā kūʻai hoʻokele ʻikepili i kuleana no ka ulu nui ʻana o nā huahana ma mua o 20 a hiki i ke kūlana blockbuster ma nā wahi o Cardiovascular, Arthritis, Neuroscience, Diabetes, and Oncology.
- He manaʻoʻiʻo paʻa e hana nā moʻomeheu hui i nā hui lanakila
- Peresidena i hala, Pharmaceutical Management Science Association of America
- BA, MBA a me Ph.D.
Pani >
Brian Cooley
Hope Peresidena kiʻekiʻe, Hui Pūʻulu a me Lymphatic Drug Development BU
- ʻO 30+ mau makahiki o ka ʻike ma ka ʻoihana biopharmaceutical a me ka ʻepekema ola
- Ua paʻa ʻo Mr. Cooley i nā kūlana alakaʻi kūʻai like ʻole, kūʻai aku, a me nā ʻoihana ʻoihana ma nā hui fortune 500 a ua alakaʻi ʻo ia i ka ʻohi kālā kūleʻa a hoʻomaka i nā hana no nā hui ʻenehana mālama ola.
- Ma mua o kona komo ʻana i Sorrento, ua alakaʻi ʻo Mr.
- Eia kekahi, ua alakaʻi nui ʻo ia i ka BD, i ka laikini, a me ka hoʻohui ʻana i nā hana ma waena o ka honua a me ka US Ua komo pū me nā ʻoihana hoʻonui pāʻoihana he nui ʻEulopa, Middle East a me ʻApelika, a me kahi ʻaelike hui pū $400MM i ka laikini, hoʻomohala a hoʻolaha. ʻO ka agonist GLP-1 mua
- ʻO ka mea hou loa, ʻo Mr. Cooley ʻo CBO no ka Sofusa Business Unit ma Kimberly-Clark a alakaʻi i ka holomua o ke kūʻai aku a me ka hoʻohui ʻana i loko. Sorrento Therapeutics. Ke hoʻomau nei ʻo ia i ke alakaʻi ʻana i ka mahele Lymphatic Drug Delivery system ma Sorrento.
- BS
Pani >
Bill Farley
Hope Peresidena Hoʻomohala Pāʻoihana
- ʻO 30+ mau makahiki o ka ʻike ma ka Hoʻomohala ʻoihana, Kūʻai a me nā hana alakaʻi i ka ʻike ʻana i ka lāʻau lapaʻau, hoʻomohala a me ka hui pū ʻana
- Ma mua o kona komo ʻana iā Sorrento, ua paʻa ʻo Mr. Farley i nā kūlana alakaʻi ma HitGen, WuXi Apptec, VP o ka hale ʻo Key Accounts a alakaʻi i kahi hui BD honua; ʻO ChemDiv, VP o BD ma, ke alakaʻi nei i nā hana he nui e hana i nā hui therapeutic hou ma CNS, Oncology a me Anti-infectives.
- Ua lawelawe ʻo Mr. Farley ma ke ʻano he kūkākūkā i nā hui hoʻokele hoʻokele like ʻole a me nā BOD e hoʻomohala a kūʻai aku i nā waiwai me nā mea like me Xencor, Caliper Technologies a me Stratagene
- Ua kūkulu ʻo ia i kahi pūnaewele paʻa i nā hui lāʻau lapaʻau, biotech a me ke kaiāulu Venture Capital. Ua haʻi ʻo Mr. Farley ma nā ʻaha kūkā he nui a ua paʻi ʻia ma nā ʻano puke pai like ʻole
- BS
Pani >
Alexis Nahama
Hope Pelekikena Nui Neurotherapeutics BU
- Ke alakaʻi nei ʻo Kauka Nahama i nā papahana hoʻomohala lāʻau ola kino kanaka a me nā holoholona RTX
- Ma ke ʻano he hui alakaʻi lālā, kākoʻo ʻo Dr. Nahama i ka hoʻomohala ʻana i ka hoʻolālā, mālama i nā papahana waiwai kiʻekiʻe, hoʻomaʻamaʻa i ka hele ʻana i ka hoʻomākaukau ʻana i ka mākeke, a hānai i nā hana kuʻikahi o waho.
- Hoʻoikaika ikaika i nā manawa unuhi e hoʻolalelale i nā papahana hoʻomohala kanaka me ka lawe ʻana i nā ʻenehana i loaʻa ʻole i nā holoholona.
- Ma mua o kona komo ʻana i Sorrento, ua lilo ʻo ia ma mua o 25 mau makahiki e paʻa ana i nā kuleana hoʻokō honua e hana ana ma Life Science a me Biotechnology no Sanofi, Colgate, Novartis, Merck, VCA Antech a me VetStem Biopharma
- ʻO DVM me ka ʻoihana mua i kālele ʻia i ka R&D ma ka wahi ʻeha (nā hoʻokolohua lapaʻau no nā holoholona)
Pani >